MoCRA: Draft Guidance on Registration and Listing of Cosmetic Facilities and Products On 7 August 2023, the U.S. Food and Drug Administration, issued draft guidance on cosmetic product facility registrations and product listings, as mandated by the Modernization of Cosmetics Regulation Act of 2022 (MoCRA). The draft guidance will assist stakeholders with cosmetic product facility registration and product listing submissions to FDA,...
The European Commission has approved a new Regulation concerning the use of CMR substances (Carcinogenic, Mutagenic, or Toxic) in cosmetic products. On July 19, 2023, the Commission adapted Regulation (2023/1490), which amends Annex II of the Cosmetic Products Regulation to include substances classified as carcinogenic, mutagenic or toxic to reproduction, in accordance with Delegated Regulation (2022/692). Contents of the Regulation on CMR...
MoCRA cosmetics - the "biggest" regulation change in the US On 29 December 2022, President Biden signed into law the Consolidated Appropriations Act, 2023. Modernization of Cosmetic Regulation. Act, “MoCRA”, is the first major update to the Food and Drug Administration's (FDA) cosmetics authorities since 1938 and introduces significant changes. MOCRA'S KEY PROVISIONS Sec. 605 Adverse Effect Adverse effects caused by the use of...
On 1 February 2022, the European Commission released Regulation (EU) 2022/135 amending Cosmetic Regulation as regards the use of Methyl-N-methylanthranilate in cosmetic products....
CBD cosmetics: Regulation about its use CBD is, without question, becoming increasingly popular in all kinds of products. The active ingredient comes from marijuana and has enormous therapeutic potential, and is now gaining traction in the cosmetics industry, too. Cannabis sativa is the botanical name for marijuana, and hemp. The difference between the two is the cannabinoid content:Marijuana: contains THC (psychotropic) and...